Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (4.026)

1

Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors

enthalten in: Journal for immunotherapy of cancer | 2024

von Frentzas, S. | Austria Mislang, A. | Lemech, C. | +7

2

Safety and Efficacy of Brolucizumab in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy : A Systematic Review and Meta-Analysis

enthalten in: Seminars in ophthalmology | 2024

von Abu Serhan, H. | Taha, M. | Abuawwad, M. | +7

3

Short Term Effect of Pre-Operative Anti-VEGF on Angiogenic and Fibrotic Profile of Fibrovascular Membranes of Proliferative Diabetic Retinopathy

enthalten in: Investigative ophthalmology & visual science | 2024

von Fadakar, K. | Rahmani, S. | Tedeschi, T. | +2

4

Off-label use of intravitreal bevacizumab : A global conundrum

enthalten in: Indian journal of ophthalmology | 2024

von Singh, S. | Saxena, S. | Akduman, L. | +1

5

A Phase 1b Study of Ivonescimab, a Programmed Cell Death Protein-1 and Vascular Endothelial Growth Factor Bispecific Antibody, as First- or Second-Line Therapy for Advanced or Metastatic Immunotherapy-Naive NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Wang, L. | Luo, Y. | Ren, S. | +17

6

Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer : A Phase 3 Randomized Clinical Trial

enthalten in: JAMA oncology | 2024

von Shiraishi, Y. | Kishimoto, J. | Sugawara, S. | +25

7

Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment

enthalten in: Journal of cellular biochemistry | 2024

von Ahamed, A. | Samanta, A. | Alam, S. | +4

8

Levosulpiride for the treatment of diabetic macular oedema : a phase 2 randomized clinical trial

enthalten in: Eye (London, England) | 2024

von Núñez-Amaro, C. | López, M. | Adán-Castro, E. | +16

9

Ranibizumab Biosimilars in Treating Retinal Disorders : A Cost-Effective Revolution?

enthalten in: Drug design, development and therapy | 2024

von Chatzimichail, E. | Pfau, K. | Gatzioufas, Z. | +1

10

Changes in the uninjected contralateral eye after intravitreal brolucizumab for exudative age-related macular degeneration

enthalten in: European journal of ophthalmology | 2024

von Mora, P. | Bellucci, C. | Radice, L. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[403]